Understanding how numerical information affects tobacco risk communication
Use and Impact of Quantitative Information in Tobacco Risk Communications
This study looks at how well people understand numbers and how that affects their views on the risks of tobacco, helping to create better health messages that encourage everyone to make healthier choices about smoking.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-10933037 on NIH RePORTER |
What this research studies
This research investigates how the ability to understand numerical information (numeracy) influences people's perceptions of tobacco risks and their decision-making regarding tobacco use. By analyzing data from various demographics, the project aims to identify how different levels of numeracy affect individuals' understanding of the risks associated with tobacco products. The findings will help create tailored public health campaigns that effectively communicate risks to diverse populations, ultimately encouraging healthier behaviors related to tobacco use.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals aged 18 and older who use tobacco products or are considering using them.
Not a fit: Patients who do not use tobacco products or are not interested in tobacco cessation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective tobacco risk communication strategies that help individuals make informed decisions about tobacco use.
How similar studies have performed: Previous research has shown that improving numeracy can enhance health communication effectiveness, suggesting that this approach may yield significant insights.
Where this research is happening
Newark, UNITED STATES
- Rutgers Biomedical and Health Sciences — Newark, United States (Active)
Researchers
- Principal investigator: Diaz, Destiny — Rutgers Biomedical and Health Sciences
- Study coordinator: Diaz, Destiny
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.